封面
市場調查報告書
商品編碼
1672706

苯二氮平類市場按產品、給藥管道、應用、分銷管道和地區分類

Benzodiazepine Drugs Market, By Product, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球苯二氮平類藥物市場規模估計為 33.568 億美元,預計到 2032 年將達到 44.203 億美元,2025 年至 2032 年的複合年成長率為 4.0%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 33.568億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 4.00% 2032 年金額預測 44.203億美元
圖:2025 年苯二氮平類藥物各地區市場佔有率(%)
苯二氮平類藥物市場-IMG1

由於主要國家焦慮和睡眠障礙盛行率不斷上升,全球苯二氮平類藥物市場正在經歷顯著成長。苯二氮平類藥物是一類促效劑,透過作用於中樞神經系統來治療失眠、焦慮、煩躁、癲癇、恐慌症和肌肉痙攣等病症。它們充當中樞神經系統抑制劑,抑制大腦的異常興奮,同時引起鎮靜。苯二氮平類藥物可增強 GABAA 受體的作用,進而調節睡眠、焦慮和肌肉緊張。此外,苯二氮平類藥物被廣泛用於焦慮和睡眠障礙的短期治療,以及緩解酒精戒斷症狀。

市場動態

生活方式的改變和壓力水平的增加導致整體焦慮症和失眠等疾病的流行,預計這將增加全球對苯二氮平類藥物的需求。根據世界衛生組織發布的報告,全球約有2.64億人患有憂鬱症和焦慮症。根據美國焦慮和憂鬱症協會的數據,超過 38% 的美國人出現焦慮症狀。擴大採用苯二氮平類藥物來控制精神健康問題症狀可能會推動全球苯二氮平類藥物市場的成長。然而,對長期使用苯二氮平類藥物的副作用(如嗜睡、頭暈、協調性和記憶力受損)的擔憂等因素可能會給市場相關人員帶來挑戰。此外,預測期內替代療法的可用性也可能阻礙市場成長。另一方面,正在開發更安全、副作用更少的苯二氮平類藥物,為不久的將來的市場成長帶來了巨大的機會。

研究的主要特點

  • 本報告對全球苯二氮平類藥物市場進行了詳細分析,並提供了預測期(2025-2032 年)的市場規模(百萬美元)和年複合成長率(CAGR%),假設基準年為 2024 年。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球苯二氮平類藥物市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。
  • 主要企業包括 Torrent Pharmaceuticals Ltd.、Mallinckrodt Pharmaceuticals、Pfizer Inc.、Viatris (Mylan NV)、Labiana Pharmaceuticals、Bausch Health Companies, Inc.、Teva Pharmaceutical Industries Ltd.、Amneal Pharmaceuticals LLC、Sun Pharmaceutical 、Aquestive Therapeutics, Inc.、F.Hoffmann-La Roche Ltd.、Wockhardt UK Ltd.、Lupin 與 Hikma Pharmaceuticals PLC。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、規模擴大、市場擴張和行銷策略做出明智的決策。
  • 全球苯二氮平類藥物市場滿足該行業的各個相關人員的需求,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過全球苯二氮平類藥物市場分析中使用的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 製造商收益
  • 收購和合作場景
  • 產品發布/核准
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球苯二氮平類藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年全球苯二氮平類藥物市場(依產品分類)(百萬美元)

  • 介紹
  • 長效型苯二氮平類藥物
  • 氯氮卓
  • Diazepam
  • Lorazepam
  • Alprazolam
  • 氯硝西泮
  • 其他
  • 短效型苯二氮平類藥物
  • 替馬西泮
  • 咪達唑侖
  • 三唑侖
  • 其他

6. 2020 年至 2032 年按給藥途徑分類的全球苯二氮平類藥物市場(百萬美元)

  • 介紹
  • 口服
  • 注射
  • 其他

7. 2020 年至 2032 年全球苯二氮平類藥物市場(按應用分類)(百萬美元)

  • 介紹
  • 焦慮症
  • 緊張的
  • 鎮靜
  • 癲癇
  • 酒精戒斷
  • 其他

8. 2020-2032 年全球苯二氮平類藥物市場按分銷管道分類(百萬美元)

  • 介紹
  • 醫院藥房
  • 零售藥局
  • 網路藥局

9. 2020 年至 2032 年全球苯二氮平類藥物市場(按地區分類)(百萬美元)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲
      • 北非
      • 中部非洲
      • 南非

    第10章 競爭格局

    • 公司簡介
      • Torrent Pharmaceuticals Ltd.
      • Mallinckrodt Pharmaceuticals
      • Pfizer Inc.
      • Viatris(Mylan NV)
      • Labiana Pharmaceuticals
      • Bausch Health Companies, Inc.
      • Teva Pharmaceutical Industries Ltd.
      • Amneal Pharmaceuticals LLC
      • Sun Pharmaceutical Industries Ltd.
      • Aurobindo Pharma
      • Par Pharmaceutical
      • Intas Pharmaceuticals Ltd.
      • Neurelis, Inc.
      • Almatica Pharma LLC
      • Aquestive Therapeutics, Inc.
      • F.Hoffmann-La Roche Ltd.
      • Wockhardt UK Ltd
      • Lupin
      • Hikma Pharmaceuticals PLC

    第 11 章 分析師建議

    • 興衰
    • 一致的機會地圖

    第 12 章參考文獻與調查方法

    • 參考
    • 調查方法
  • 簡介目錄
    Product Code: CMI5001

    Global Benzodiazepine Drugs Market is estimated to be valued at USD 3,356.8 Mn in 2025 and is expected to reach USD 4,420.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032.

    Report Coverage Report Details
    Base Year: 2024 Market Size in 2025: USD 3,356.8 Mn
    Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
    Forecast Period 2025 to 2032 CAGR: 4.00% 2032 Value Projection: USD 4,420.3 Mn
    Figure. Benzodiazepine Drugs Market Share (%), By Region 2025
    Benzodiazepine Drugs Market - IMG1

    Global benzodiazepine drugs market has been witnessing significant growth due to rising prevalence of anxiety and sleep disorders across major countries. Benzodiazepines are a class of psychoactive drugs that are prescribed to treat conditions such as insomnia, anxiety, agitation, seizures, panic attacks and muscle spasms by their effect on the central nervous system. These act as central nervous system depressants, reducing abnormal excitement in the brain, while inducing sedation. Benzodiazepines enhance the effect of the GABAA receptors, which are responsible to regulating aspects of sleep, anxiety and muscle tension. Moreover, benzodiazepines are widely prescribed for short term management of anxiety and sleep disorders along with symptomatic relief of alcohol withdrawal.

    Market Dynamics:

    Growing prevalence of conditions like generalized anxiety disorder and insomnia due to changing lifestyle and increasing stress levels is expected to boost demand for benzodiazepine drugs globally. According to the report published by WHO, around 264 million people suffer from depression and anxiety worldwide. More than 38% of Americans had experience symptoms of anxiety, according to the Anxiety and Depression Association of America. Increasing adoption of benzodiazepines to manage symptoms of mental health issues can drive the global benzodiazepine drugs market growth. However, factors such as concerns regarding side effects associated with long term use of benzodiazepines including drowsiness, dizziness, and impaired coordination and memory can pose a challenge for market players. Moreover, availability of alternative treatments can hamper the market growth over the forecast period. Meanwhile, advancements in drug development to introduce safer variants of benzodiazepines with fewer side effects present significant opportunities for the market growth in the near future.

    Key Features of the Study:

    • This report provides an in-depth analysis of the global benzodiazepine drugs market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
    • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
    • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
    • It profiles key players in the global benzodiazepine drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
    • Key companies covered as a part of this includes Torrent Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Pfizer Inc., Viatris (Mylan N.V.), Labiana Pharmaceuticals, Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Par Pharmaceutical, Intas Pharmaceuticals Ltd., Neurelis, Inc., Almatica Pharma LLC, Aquestive Therapeutics, Inc., F.Hoffmann-La Roche Ltd., Wockhardt UK Ltd, Lupin, Hikma Pharmaceuticals PLC
    • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
    • Global benzodiazepine drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
    • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global benzodiazepine drugs market

    Detailed Segmentation

    • By Product:
      • Long Acting Benzodiazepines
      • Chlordiazepoxide
      • Diazepam
      • Lorazepam
      • Alprazolam
      • Clonazepam
      • Others
      • Short Acting Benzodiazepines
      • Temazepam
      • Midazolam
      • Triazolam
      • Others
    • By Route of Administration:
      • Oral
      • Injectables
      • Others
    • By Application:
      • Anxiety Disorders
      • Nervousness
      • Sedation
      • Seizures
      • Alcohol Withdrawal
      • Others
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
    • Company Profiles:
      • Torrent Pharmaceuticals Ltd.
      • Mallinckrodt Pharmaceuticals
      • Pfizer Inc.
      • Viatris (Mylan N.V.)
      • Labiana Pharmaceuticals
      • Bausch Health Companies, Inc.
      • Teva Pharmaceutical Industries Ltd.
      • Amneal Pharmaceuticals LLC
      • Sun Pharmaceutical Industries Ltd.
      • Aurobindo Pharma
      • Par Pharmaceutical
      • Intas Pharmaceuticals Ltd.
      • Neurelis, Inc.
      • Almatica Pharma LLC
      • Aquestive Therapeutics, Inc.
      • Hoffmann-La Roche Ltd.
      • Wockhardt UK Ltd
      • Lupin
      • Hikma Pharmaceuticals PLC

    Table of Contents

    1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations

    2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)

    3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Manufacturer Revenue
    • Acquisitions and Partnerships Scenario
    • Product Launches/Approvals
    • Funding and Investments
    • PEST Analysis
    • Porter's Analysis

    4. Global Benzodiazepine Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market

    5. Global Benzodiazepine Drugs Market, By Product, 2020 - 2032, (USD Mn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Long Acting Benzodiazepines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
    • Short Acting Benzodiazepines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Temazepam
    • Midazolam
    • Triazolam
    • Others

    6. Global Benzodiazepine Drugs Market, By Route of Administration, 2020 - 2032, (USD Mn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Oral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Injectables
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

    7. Global Benzodiazepine Drugs Market, By Application, 2020 - 2032, (USD Mn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Anxiety Disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Nervousness
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Sedation
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Seizures
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Alcohol Withdrawal
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

    8. Global Benzodiazepine Drugs Market, By Distribution Channel, 2020 - 2032, (USD Mn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

    9. Global Benzodiazepine Drugs Market, By Region, 2020 - 2032, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, For Region, 2021-2032
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
        • North Africa
        • Central Africa
        • South Africa

    10. Competitive Landscape

    • Company Profiles
      • Torrent Pharmaceuticals Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Mallinckrodt Pharmaceuticals
      • Pfizer Inc.
      • Viatris (Mylan N.V.)
      • Labiana Pharmaceuticals
      • Bausch Health Companies, Inc.
      • Teva Pharmaceutical Industries Ltd.
      • Amneal Pharmaceuticals LLC
      • Sun Pharmaceutical Industries Ltd.
      • Aurobindo Pharma
      • Par Pharmaceutical
      • Intas Pharmaceuticals Ltd.
      • Neurelis, Inc.
      • Almatica Pharma LLC
      • Aquestive Therapeutics, Inc.
      • F.Hoffmann-La Roche Ltd.
      • Wockhardt UK Ltd
      • Lupin
      • Hikma Pharmaceuticals PLC

    11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

    12. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact